Exploratory test group for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Dec 2025: Trial started, NCT07552389
  2. 27 Apr 2026: Trial registered, NCT07552389

The trials

NCT07552389: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

State
Under way
Phase
Phase 3
People
228 planned
Started
18 Dec 2025
Primary completion
Dec 2028
Arms
Exploratory test group
Results
None posted
  1. 18 Dec 2025: Trial started
  2. 27 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.